# A Pilot Study of the Effects of Botulinum Toxin in the Treatment of Provoked Vestibulodynia

> **NCT02858219** · PHASE3 · COMPLETED · sponsor: **Centre Hospitalier Universitaire de Besancon** · enrollment: 60 (actual)

## Conditions studied

- Vestibulodynia

## Interventions

- **DRUG:** Botulinum Toxin Type A
- **OTHER:** Saline solution
- **OTHER:** Indexes

## Key facts

- **NCT ID:** NCT02858219
- **Lead sponsor:** Centre Hospitalier Universitaire de Besancon
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05-04
- **Primary completion:** 2019-02-11
- **Final completion:** 2019-02-11
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2022-11-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02858219

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02858219, "A Pilot Study of the Effects of Botulinum Toxin in the Treatment of Provoked Vestibulodynia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02858219. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*